LIFECORE BIOMEDICAL INC DE
For the period ended Aug 25, 2024. Filed Oct 4, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Aug 25, 2024 · Filed Oct 4, 2024
Contents
Restructuring Costs
- Restructuring Costs
The following table summarizes the restructuring costs recognized in the Company’s Condensed Consolidated Statements of Operations, in connection with the previously announced restructuring plan. These costs are included within selling, general, and administrative costs on the consolidated statements of operations.
| Three Months Ended | ||
|---|---|---|
| August 25, 2024 | August 27, 2023 | |
| Employee severance and benefit costs | $439 | $(18) |
| Lease costs | — | 7 |
| Other restructuring costs | 44 | 1 |
| Total restructuring costs | $483 | $(10) |
The following table presents the movement of the restructuring costs liability from May 26, 2024 through August 25, 2024, excluding discontinued operations, within current liabilities in the Condensed Consolidated Balance Sheet:
| May 26, 2024 | Expense | Payments | August 25, 2024 | |
|---|---|---|---|---|
| Employee severance and benefit costs | $217 | $439 | $(397) | $259 |
| Lease costs | 4,290 | — | — | 4,290 |
| Other restructuring costs | 264 | 44 | (40) | 268 |
| $4,771 | $483 | $(437) | $4,817 |
-7-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.